VASP and familial pancreatic carcinoma: from the Hormel Institute in Austin, Minnesota, USA, and colleagues showed that levels of this actin-binding protein, known as vasodilator-stimulated phosphoprotein (VASP), are elevated in most patients with advanced colon and pancreatic cancers and that higher VASP expression levels are linked to liver metastasis and poorer patients’ outcomes.